Can Chlorthalidone Cause Constipation?
Yes, chlorthalidone can cause constipation, though it is an uncommon adverse effect reported in clinical studies.
Evidence from Clinical Trials
The most direct evidence comes from a 2014 interventional study in patients with chronic kidney disease and poorly controlled hypertension, where constipation was documented as one of the adverse events occurring in 1 out of 14 subjects (7%) treated with chlorthalidone 1. This study specifically tracked adverse effects over 12 weeks of treatment, making it the highest quality direct evidence linking chlorthalidone to constipation.
Mechanism and Context
While constipation is not listed among the primary adverse effects in the FDA drug label for chlorthalidone 2, the mechanism by which it could occur relates to:
- Electrolyte disturbances: Chlorthalidone commonly causes hypokalemia (low potassium), which can impair smooth muscle function in the gastrointestinal tract 3, 1
- Volume depletion: The drug produces copious diuresis with greatly increased excretion of sodium and chloride, leading to volume contraction 2, 1
- Dehydration effects: Reduced total body water from diuretic action may contribute to harder stools and constipation
Clinical Significance and Monitoring
The more common and clinically significant adverse effects of chlorthalidone are electrolyte abnormalities rather than constipation 3, 1. When prescribing chlorthalidone, priority monitoring should focus on:
- Hypokalemia (occurs in 8.5% at 4 years in major trials) 3
- Hypomagnesemia (higher risk than with hydrochlorothiazide) 3
- Hyperuricemia 1
- Hyponatremia 1
These electrolyte disturbances typically occur within the first few weeks of therapy and require careful monitoring 1.
Practical Considerations
If a patient on chlorthalidone develops constipation, consider:
- Check serum potassium levels, as hypokalemia may be the underlying cause and requires correction 3, 1
- Assess hydration status and encourage adequate fluid intake
- Review all medications, as constipation may be multifactorial in patients on multiple antihypertensive agents
- The adverse effect profile shows chlorthalidone has higher potency than hydrochlorothiazide, leading to more frequent electrolyte disturbances at equivalent doses 3